We are live on ! Find out more
GNPX icon

Genprex

8 hedge funds and large institutions have $426K invested in Genprex in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0%0.01% (+0.01%)

60% less funds holding

Funds holding: 208 (-12)

63% less capital invested

Capital invested by funds: $1.17M → $426K (-$739K)

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
8
Holders Change
-12
Holders Change %
-60%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
14
Calls
Puts
Net Calls
Net Calls Change

GNPX Hedge Fund Activity: Q1 2024 in Review

8 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2024, worth a combined $426K — down 63% from $1.17M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of GNPX and 2 opened new positions — a net loss of 12 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $586K. The largest seller was Vanguard Group, cutting an estimated $184K.

  • 8 institutional investors held Genprex (GNPX) as of Q1 2024, down from 20 in Q4 2023.
  • Funds reported $426K of Genprex stock for Q1 2024, down 63% quarter-over-quarter.
  • 2 funds opened new Genprex positions in Q1 2024 and 14 closed out, a net change of -12 holders.
  • The largest Genprex buyer in Q1 2024 was Armistice Capital, an estimated $586K added.
  • The largest Genprex seller in Q1 2024 was Vanguard Group, an estimated $184K sold.

Based on aggregated 13F filings for Q1 2024.